Fortress Biotech, Inc.
FBIOUS売上高
$63M
百万USD
営業利益
$-70M
百万USD
純利益
$7M
百万USD
ROE
13.7%
最新FY
EPS
$-0.07
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $12M | $-9M | - |
| FY2021 | Q2 | $18M | $-4M | - |
| FY2021 | Q3 | $21M | $-21M | - |
| FY2021 | FY | $69M | $-65M | - |
| FY2022 | Q1 | $24M | $-16M | $-0.18 |
| FY2022 | Q2 | $19M | $-21M | $-0.24 |
| FY2022 | Q3 | $17M | $-23M | $-0.25 |
| FY2022 | FY | $76M | $-87M | $-0.97 |
| FY2023 | Q1 | $12M | $-22M | $-0.21 |
| FY2023 | Q2 | $17M | $-25M | $-0.24 |
| FY2023 | Q3 | $35M | $-5M | $-0.94 |
| FY2023 | FY | $85M | $-61M | $-8.47 |
| FY2024 | Q1 | $13M | $-15M | - |
| FY2024 | Q2 | $15M | $-11M | $-0.73 |
| FY2024 | Q3 | $15M | $-13M | $-0.76 |
| FY2024 | FY | $58M | $-46M | $-2.69 |
| FY2025 | Q1 | - | $-11M | $-0.48 |
| FY2025 | Q2 | $16M | $15M | $0.45 |
| FY2025 | Q3 | $18M | $6M | $0.11 |
| FY2025 | FY | $63M | $7M | $-0.07 |
| FY2026 | Q1 | $16M | $110M | $2.82 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | $16M | $188M | $27M | $37M | $46M | $69M | $76M | $85M | $58M | $63M |
| 営業利益 | $-66M | $-101M | $-120M | $-111M | $-94M | $-189M | $-204M | $-142M | $-110M | $-70M |
| 純利益 | $-55M | $-67M | $-84M | $-40M | $-47M | $-65M | $-87M | $-61M | $-46M | $7M |
| 総資産 | $171M | $246M | $141M | $226M | $329M | $397M | $294M | $168M | $144M | $186M |
| 純資産 | $83M | $121M | $20M | $73M | $197M | $226M | $50M | $2M | $-2M | $62M |
| 自己資本 | $38M | $53M | $2M | $26M | $100M | $109M | $42M | $23M | $23M | $50M |
| 営業CF | - | $-85M | $-99M | $-95M | $-84M | $-117M | $-179M | $-128M | $-80M | $-66M |
| EPS | - | - | - | - | - | - | $-0.97 | $-8.47 | $-2.69 | $-0.07 |
| BPS | $0.77 | $1.02 | $0.03 | $0.33 | - | - | - | - | - | - |
| ROE | -143.1% | -127.2% | -4543.6% | -152.4% | -46.4% | -59.5% | -207.5% | -269.0% | -202.3% | 13.7% |